OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
Yi Huang, Huanyu Wang, Yize Hao, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 6, pp. 716-727
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 493

The NLRP3 inflammasome: activation and regulation
Jie Xu, Gabriel Núñez
Trends in Biochemical Sciences (2022) Vol. 48, Iss. 4, pp. 331-344
Closed Access | Times Cited: 253

Interleukin-1β and Cancer
Cédric Rébé, François Ghiringhelli
Cancers (2020) Vol. 12, Iss. 7, pp. 1791-1791
Open Access | Times Cited: 226

NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
Chloe M McKee, Rebecca C. Coll
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 3, pp. 937-952
Open Access | Times Cited: 159

How location and cellular signaling combine to activate the NLRP3 inflammasome
Anil Akbal, Alesja Dernst, Marta Lovotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 120

NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Sara Socorro Faria, Susan Costantini, Vladmir Cláudio Cordeiro de Lima, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 119

Involvement of inflammasomes in tumor microenvironment and tumor therapies
Ziqi Zhang, Xue Li, Yang Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 42

A 10-year bibliometric analysis in the field of osteosarcoma treatment from 2014 to 2023
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

The NLRP3–inflammasome as a sensor of organelle dysfunction
Paula I. Seoane, Bali Lee, Christopher Hoyle, et al.
The Journal of Cell Biology (2020) Vol. 219, Iss. 12
Open Access | Times Cited: 125

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Anna Gritsenko, Yu Shi, Fatima Martín‐Sánchez, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120

Mechanisms of NLRP3 priming in inflammaging and age related diseases
Anna Gritsenko, Jack Green, David Brough, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 55, pp. 15-25
Open Access | Times Cited: 92

Recent insights into the regulatory networks of NLRP3 inflammasome activation
Alexander N.R. Weber, Zsofia Bittner, Sangeetha Shankar, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 23
Open Access | Times Cited: 70

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
Sonia Missiroli, Mariasole Perrone, Caterina Boncompagni, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 67

NF-κB: A Double-Edged Sword Controlling Inflammation
Danhui Liu, Zhenyu Zhong, Michael Karin
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1250-1250
Open Access | Times Cited: 61

Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression
Yueli Xu, Jiaxian Yan, Ye Tao, et al.
Science (2022) Vol. 377, Iss. 6610, pp. 1085-1091
Closed Access | Times Cited: 45

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance
Han-Ying Cheng, Chia-Hsin Hsieh, Po‐Han Lin, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004832-e004832
Open Access | Times Cited: 45

Exosomal miR-23b from bone marrow mesenchymal stem cells alleviates oxidative stress and pyroptosis after intracerebral hemorrhage
Yuhua Fan, Zhiyi He, Wenxu Zheng, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 3, pp. 560-560
Open Access | Times Cited: 39

Divergent functions of NLRP3 inflammasomes in cancer: a review
Alireza Shadab, Mohamad Mahjoor, Mohammad Abbasi‐Kolli, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32

Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases
Ying‐Hao Han, Xiaodong Liu, Meihua Jin, et al.
Inflammation Research (2023) Vol. 72, Iss. 9, pp. 1839-1859
Closed Access | Times Cited: 29

Inflammasome: structure, biological functions, and therapeutic targets
Dai Ya-li, Jing Zhou, Chunmeng Shi
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 27

Role of pyroptosis in the pathogenesis and treatment of diseases
Xiangyu Jin, Yinchu Ma, Didi Liu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 26

Fantastic voyage: The journey of NLRP3 inflammasome activation
Xiangyong Que, Sihao Zheng, Qibin Song, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 819-829
Open Access | Times Cited: 24

Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7
Xiangyu Jin, Didi Liu, Xinru Zhou, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 12, pp. 101310-101310
Open Access | Times Cited: 22

PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation
Milad Ashrafizadeh, Masoud Najafi, Hui Li Ang, et al.
Biomedicines (2020) Vol. 8, Iss. 8, pp. 264-264
Open Access | Times Cited: 60

Page 1 - Next Page

Scroll to top